Chelsea S. Hamill
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chelsea S. Hamill has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Kevin J. Sykes
Department of Otolaryngology – Head and Neck Surgery University of Kansas Medical Center Kansas City Kansas USA
3 shared publications - Clare Richardson
Department of Otolaryngology - Head and Neck Surgery, University Hospitals Cleveland Medical Center - Case Western Reserve University, 11100 Euclid Ave, Cleveland, OH 44106, United States of America
2 shared publications - Jason Eric Thuener
Case Western Reserve University School of Medicine Cleveland Ohio USA
2 shared publications Kate Clancy
Department of Otolaryngology‐Head and Neck Surgery University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine Cleveland Ohio USA
2 shared publicationsKevin J. Sykes
Department of Otolaryngology‐ Head and Neck Surgery University of Kansas Medical Center Kansas City Kansas U.S.A.
2 shared publications- Quintin Pan
School of Medicine, Case Western Reserve University, Cleveland, OH
2 shared publications
Latest Publications
- 31 January 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 172 (4) , 1318-1327
Sociodemographic and Clinical Determinants of 12‐Month Decision Regret for Head and Neck Cancer Patients
Objective: This study aims to identify factors associated with increased decision regret (DR) 12 months following treatment among head and neck cancer (HNC) patients.Study Design: A retrospective observational cohort study.Setting: Patients with newly diagnosed HNC at an academic tertiary care center from 2018 to 2023.Methods: Data from a patient registry assessing quality of life (QOL), DR, social support, and anxiety at initial diagnosis and 12 months post‐treatment were analyzed. Only patients who completed the decision regret questionnaire at 12 months were included.Results: Among 225 participants, 60% experienced mild DR and 28% reported moderate to severe regret. Stronger regret was associated with advanced disease presentation, free flap reconstructive surgery, chemoradiation, and disease recurrence. Patients with more severe regret had lower QOL at baseline and 12 months, higher anxiety at 12 months, and lower social support at 12 months. Multivariable analysis identified multimodal treatment including radiation (adjusted odds ratio [aOR] 3.67, 95% confidence interval [CI] [1.25‐10.78], P = .018), lower 12‐month social support (aOR 1.03, 95% CI [1.00‐1.05], P = .039), and decreases in QOL (aOR 1.03, 95% CI [1.00‐1.06], P = .024) as independent predictors of increased DR.Conclusion: Treatment involving radiation, lower concurrent social support, and diminished QOL are associated with DR 12 months after treatment. This highlights the potential of interventions aimed at enhancing social support, addressing treatment‐related sequelae, and strengthening shared decision‐making to prevent regret. Further studies are needed to elucidate factors driving regret in HNC patient subgroups and assess the efficacy of proposed mitigative interventions.
- 31 January 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 172 (4) , 1318-1327
Sociodemographic and Clinical Determinants of 12‐Month Decision Regret for Head and Neck Cancer Patients
Objective: This study aims to identify factors associated with increased decision regret (DR) 12 months following treatment among head and neck cancer (HNC) patients.Study Design: A retrospective observational cohort study.Setting: Patients with newly diagnosed HNC at an academic tertiary care center from 2018 to 2023.Methods: Data from a patient registry assessing quality of life (QOL), DR, social support, and anxiety at initial diagnosis and 12 months post‐treatment were analyzed. Only patients who completed the decision regret questionnaire at 12 months were included.Results: Among 225 participants, 60% experienced mild DR and 28% reported moderate to severe regret. Stronger regret was associated with advanced disease presentation, free flap reconstructive surgery, chemoradiation, and disease recurrence. Patients with more severe regret had lower QOL at baseline and 12 months, higher anxiety at 12 months, and lower social support at 12 months. Multivariable analysis identified multimodal treatment including radiation (adjusted odds ratio [aOR] 3.67, 95% confidence interval [CI] [1.25‐10.78], P = .018), lower 12‐month social support (aOR 1.03, 95% CI [1.00‐1.05], P = .039), and decreases in QOL (aOR 1.03, 95% CI [1.00‐1.06], P = .024) as independent predictors of increased DR.Conclusion: Treatment involving radiation, lower concurrent social support, and diminished QOL are associated with DR 12 months after treatment. This highlights the potential of interventions aimed at enhancing social support, addressing treatment‐related sequelae, and strengthening shared decision‐making to prevent regret. Further studies are needed to elucidate factors driving regret in HNC patient subgroups and assess the efficacy of proposed mitigative interventions.
- Open Access
- 1 June 2022
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 7 (4) , 988-993
Treatment failure patterns are similar between p16− and p16+ oropharyngeal squamous cell carcinomas
Background: The incidence of p16+ oropharyngeal squamous cell carcinoma (OPSCC) has been increasing. The notion that p16+ OPSCC has a propensity for atypical and disseminating metastasis has gained traction. We compared treatment failure patterns in p16+ and p16− OPSCC and evaluated survival impact.Methods: Retrospective analysis of patients with recurrent/metastatic OPSCC disease between 1/2009 and 12/2019.Results: Thirty‐eight p16+ and 36 p16− patients were identified. Three distinct failure patterns (distant vs. locoregional, atypical vs. typical, and disseminating vs. non‐disseminating) were studied. No significant differences were found between p16+ and p16− patients. Multivariate analysis showed p16 status was an independent prognostic biomarker; p16+ patients have a favorable overall survival compared to p16− patients (HR 0.34, 95% CI 0.16–0.77; P = .005).Conclusions: We challenge the view that p16+ OPSCC exhibits a distinctive treatment failure pattern and showed that p16 status impacts patient survival independent of disease progression.
- 1 June 2022
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 7 (4) , 988-993
Open AccessTreatment failure patterns are similar between p16− and p16+ oropharyngeal squamous cell carcinomas
Background: The incidence of p16+ oropharyngeal squamous cell carcinoma (OPSCC) has been increasing. The notion that p16+ OPSCC has a propensity for atypical and disseminating metastasis has gained traction. We compared treatment failure patterns in p16+ and p16− OPSCC and evaluated survival impact.Methods: Retrospective analysis of patients with recurrent/metastatic OPSCC disease between 1/2009 and 12/2019.Results: Thirty‐eight p16+ and 36 p16− patients were identified. Three distinct failure patterns (distant vs. locoregional, atypical vs. typical, and disseminating vs. non‐disseminating) were studied. No significant differences were found between p16+ and p16− patients. Multivariate analysis showed p16 status was an independent prognostic biomarker; p16+ patients have a favorable overall survival compared to p16− patients (HR 0.34, 95% CI 0.16–0.77; P = .005).Conclusions: We challenge the view that p16+ OPSCC exhibits a distinctive treatment failure pattern and showed that p16 status impacts patient survival independent of disease progression.
- Open Access
Impact of p16 Status and Anatomical Site in Anti-PD-1 Immunotherapy-Treated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients
In head and neck squamous cell carcinoma (HNSCC), anti-PD-1 inhibitors are approved for recurrent/metastatic (R/M) disease and anticipated to expand to other indications. The impact of p16 status and anatomical site on overall survival (OS) in immunotherapy-treated HNSCC patients remains unresolved. We performed a retrospective analysis of R/M HNSCC patients receiving anti-PD-1 immunotherapy at our academic medical center with an extensive community satellite network. Fifty-three R/M HNSCC patients were treated with anti-PD-1 immunotherapy and had a median OS of 6 months. Anatomical site was associated with distinct OS; oropharynx and larynx patients have superior OS compared to oral cavity patients. Analysis of the OPSCC subset showed p16+ status as a favorable, independent prognostic biomarker (HR 7.67 (1.23–47.8); p = 0.029). Further studies to assess the link between anatomical site, p16 status, and anti-PD-1 treatment outcomes in large cohorts of R/M HNSCC patients managed in real-world clinical practices and clinical trials should be prioritized.
Open AccessImpact of p16 Status and Anatomical Site in Anti-PD-1 Immunotherapy-Treated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients
In head and neck squamous cell carcinoma (HNSCC), anti-PD-1 inhibitors are approved for recurrent/metastatic (R/M) disease and anticipated to expand to other indications. The impact of p16 status and anatomical site on overall survival (OS) in immunotherapy-treated HNSCC patients remains unresolved. We performed a retrospective analysis of R/M HNSCC patients receiving anti-PD-1 immunotherapy at our academic medical center with an extensive community satellite network. Fifty-three R/M HNSCC patients were treated with anti-PD-1 immunotherapy and had a median OS of 6 months. Anatomical site was associated with distinct OS; oropharynx and larynx patients have superior OS compared to oral cavity patients. Analysis of the OPSCC subset showed p16+ status as a favorable, independent prognostic biomarker (HR 7.67 (1.23–47.8); p = 0.029). Further studies to assess the link between anatomical site, p16 status, and anti-PD-1 treatment outcomes in large cohorts of R/M HNSCC patients managed in real-world clinical practices and clinical trials should be prioritized.
- Open Access
- 30 April 2021
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 320 (6) , H2283-H2294
Fibroblast growth factor 23 (FGF23) induces ventricular arrhythmias and prolongs QTc interval in mice in an FGF receptor 4-dependent manner
Here we provide direct evidence that fibroblast growth factor 23 (FGF23), a phosphaturic hormone elevated in chronic kidney disease, is proarrhythmic. FGF23 acutely triggered ventricular arrhythmias and prolonged corrected QT interval (QTc) in isolated mouse hearts and in vivo. FGF23 also increased Ca2+ levels in ventricular muscle tissue. Blockade of the FGF receptor 4 signaling pathway using a monoclonal antibody ameliorated ventricular arrhythmias, QTc prolongation, and elevated ventricular Ca2+ induced by FGF23, and may represent a potential therapeutic target in chronic kidney disease.
- 30 April 2021
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 320 (6) , H2283-H2294
Open AccessFibroblast growth factor 23 (FGF23) induces ventricular arrhythmias and prolongs QTc interval in mice in an FGF receptor 4-dependent manner
Here we provide direct evidence that fibroblast growth factor 23 (FGF23), a phosphaturic hormone elevated in chronic kidney disease, is proarrhythmic. FGF23 acutely triggered ventricular arrhythmias and prolonged corrected QT interval (QTc) in isolated mouse hearts and in vivo. FGF23 also increased Ca2+ levels in ventricular muscle tissue. Blockade of the FGF receptor 4 signaling pathway using a monoclonal antibody ameliorated ventricular arrhythmias, QTc prolongation, and elevated ventricular Ca2+ induced by FGF23, and may represent a potential therapeutic target in chronic kidney disease.
- 2 April 2021
- Published by Wiley in The Laryngoscope
- Vol. 131 (10) , 2211-2218
Initiation of a Night Float System in an Otolaryngology Residency: Resident Perception and Impact on Operative Volume
Objectives: Evaluate resident perception on implementation of a night float (NF) system to an otolaryngology residency program. We compared these perceptions to Accreditation Council for Graduate Medical Education (ACGME) case log data.Methods: A retrospective anonymous survey was sent to residents and alumni graduating between 2015 and 2023. Deidentified ACGME case log information was then examined for key indicator (KI) cases from post graduate year (PGY) 2 and PGY5.Results: Thirty (93.8%) residents and alumni responded. Residents with NF answered more positively compared to those without NF on following duty hour violations: 80‐hour work week, 1‐in‐7 days off, 1 call every 3 days, adequate time between shifts, and allotted time after a 24‐hour shift. Residents most commonly agreed that NF has improved patient care, resident education, and resident morale. Although residents with NF were neutral on PGY2 case volume effects, they disagreed that it affected overall case volume. The only KIs that differed for both PGY2 and PGY5s were airway cases (P = .004 vs P = .002) and bronchoscopy (P = .02 vs P = .006), which were significantly higher for those with NF. Thyroid surgery was the only KI higher for the residents without NF and spanned all PGY levels.Conclusion: Residents and alumni agreed that NF implementation had a positive effect on duty hour violations. The NF system does not have significant impact on case volume.Level of Evidence: 4 Laryngoscope, 131:2211–2218, 2021
- 2 April 2021
- Published by Wiley in The Laryngoscope
- Vol. 131 (10) , 2211-2218
Initiation of a Night Float System in an Otolaryngology Residency: Resident Perception and Impact on Operative Volume
Objectives: Evaluate resident perception on implementation of a night float (NF) system to an otolaryngology residency program. We compared these perceptions to Accreditation Council for Graduate Medical Education (ACGME) case log data.Methods: A retrospective anonymous survey was sent to residents and alumni graduating between 2015 and 2023. Deidentified ACGME case log information was then examined for key indicator (KI) cases from post graduate year (PGY) 2 and PGY5.Results: Thirty (93.8%) residents and alumni responded. Residents with NF answered more positively compared to those without NF on following duty hour violations: 80‐hour work week, 1‐in‐7 days off, 1 call every 3 days, adequate time between shifts, and allotted time after a 24‐hour shift. Residents most commonly agreed that NF has improved patient care, resident education, and resident morale. Although residents with NF were neutral on PGY2 case volume effects, they disagreed that it affected overall case volume. The only KIs that differed for both PGY2 and PGY5s were airway cases (P = .004 vs P = .002) and bronchoscopy (P = .02 vs P = .006), which were significantly higher for those with NF. Thyroid surgery was the only KI higher for the residents without NF and spanned all PGY levels.Conclusion: Residents and alumni agreed that NF implementation had a positive effect on duty hour violations. The NF system does not have significant impact on case volume.Level of Evidence: 4 Laryngoscope, 131:2211–2218, 2021
- 1 January 2021
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 140, 110540
Tracheostomy in the pediatric trisomy 21 population
- 1 January 2021
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 140, 110540
Tracheostomy in the pediatric trisomy 21 population
- 2 December 2020
- Published by Wiley in The Laryngoscope
- Vol. 131 (6) , 1291-1296
Cancellous Tibial Bone Graft for Malunion after Mandibular Reconstruction in Head and Neck Cancer
Objectives/Hypothesis While nonunion after mandibular reconstruction for head and neck surgery is rare, literature exploring management is scarce. Our primary objective was to determine success rates of tibial bone graft (TBG) in achieving mandibular union. Secondary objectives include determining factors that contribute to failure of TBG. Study Design Retrospective Chart Review. Methods Retrospective chart review between January 1, 2008 and December 31, 2018. Patients who underwent a mandibulotomy or mandibulectomy with osteocutaneous free flap reconstruction were identified. Patients who were pursuing dental rehabilitation, subsequently diagnosed with mandibular nonunion and received a cancellous TBG were assessed. Results The 15 patients meeting inclusion criteria were mostly male (67%), white (87%), and nonsmokers (67%) with a median age of 64 (IQR = 60–73). Successful union occurred in 13 of 18 (72%) TBGs and the majority (63%) had a partial union documented at the time of surgery. Five patients (83%) who initially had a mandibulotomy achieved union compared to 78% of those with osteocutaneous reconstruction (P = 1.0). Postoperative radiation did not affect rates of union: 80% for both (P = 1.0). Patients with osteoradionecrosis (ORN) achieved union in 67% of cases compared to 75% of cases who did not have ORN (P = .86). There were similar rates of union for those who required perioperative antibiotics for infection and those without infection (67% vs. 75%, P = .86). Dental rehabilitation was achieved in 55% of patients, most commonly dentures. Conclusions This study shows that TBG can be used to achieve union for patients with malunion after head and neck cancer reconstruction. We show its successful use within the reconstructive algorithm for patients regardless of postoperative radiation for very small defects. Level of Evidence III Laryngoscope, 2020
- 2 December 2020
- Published by Wiley in The Laryngoscope
- Vol. 131 (6) , 1291-1296
Cancellous Tibial Bone Graft for Malunion after Mandibular Reconstruction in Head and Neck Cancer
Objectives/Hypothesis While nonunion after mandibular reconstruction for head and neck surgery is rare, literature exploring management is scarce. Our primary objective was to determine success rates of tibial bone graft (TBG) in achieving mandibular union. Secondary objectives include determining factors that contribute to failure of TBG. Study Design Retrospective Chart Review. Methods Retrospective chart review between January 1, 2008 and December 31, 2018. Patients who underwent a mandibulotomy or mandibulectomy with osteocutaneous free flap reconstruction were identified. Patients who were pursuing dental rehabilitation, subsequently diagnosed with mandibular nonunion and received a cancellous TBG were assessed. Results The 15 patients meeting inclusion criteria were mostly male (67%), white (87%), and nonsmokers (67%) with a median age of 64 (IQR = 60–73). Successful union occurred in 13 of 18 (72%) TBGs and the majority (63%) had a partial union documented at the time of surgery. Five patients (83%) who initially had a mandibulotomy achieved union compared to 78% of those with osteocutaneous reconstruction (P = 1.0). Postoperative radiation did not affect rates of union: 80% for both (P = 1.0). Patients with osteoradionecrosis (ORN) achieved union in 67% of cases compared to 75% of cases who did not have ORN (P = .86). There were similar rates of union for those who required perioperative antibiotics for infection and those without infection (67% vs. 75%, P = .86). Dental rehabilitation was achieved in 55% of patients, most commonly dentures. Conclusions This study shows that TBG can be used to achieve union for patients with malunion after head and neck cancer reconstruction. We show its successful use within the reconstructive algorithm for patients regardless of postoperative radiation for very small defects. Level of Evidence III Laryngoscope, 2020
- 12 November 2020
- Published by Wiley in The Laryngoscope
- Vol. 131 (6) , E1881-E1887
Prevalence of Multidrug‐Resistant Organisms in Patients Undergoing Free Flap Reconstruction
Objectives/Hypothesis: The purpose of this study is to evaluate the relationship between antibiotic prophylaxis and prevalence of multidrug‐resistant organisms (MDRO) in patients undergoing head and neck cancer reconstruction.Study Design: Retrospective Chart Review.Methods: Retrospective review of patients who underwent head and neck free flap reconstruction at our institution between 2009 to 2016.Results: Of the 145 patients that underwent head and neck tumor removal surgery using free tissue flaps to cover the defect and therafter received antibiotic prophylaxis, 30 (20.7%) developed postoperative surgical site (n = 17, 55.7%) or distant (n = 13, 43.4%) infections. Seven had a multidrug‐resistant infection, the most common with Methicillin‐Resistant Staphylococcus aureus (MRSA). There was no significant relationship between antibiotic spectrum or duration to the development of postoperative infections or MDRO. Pseudomonas and MRSA infections were low overall with only one multidrug‐resistant Pseudomonas infection.Conclusions: The choice of antibiotic prophylaxis should cover organisms these patients are at highest risk for including anaerobes and Gram‐negative organisms. A shorter duration of antibiotic prophylaxis should be considered given no increased risk of postoperative infection nor MDRO. Finally, one must be aware of the potential threat of multidrug‐resistant Pseudomonas and MRSA amongst this vulnerable population and identity these with culture driven treatment.Level of Evidence: 4 Laryngoscope, 131:E1881–E1887, 2021
- 12 November 2020
- Published by Wiley in The Laryngoscope
- Vol. 131 (6) , E1881-E1887
Prevalence of Multidrug‐Resistant Organisms in Patients Undergoing Free Flap Reconstruction
Objectives/Hypothesis: The purpose of this study is to evaluate the relationship between antibiotic prophylaxis and prevalence of multidrug‐resistant organisms (MDRO) in patients undergoing head and neck cancer reconstruction.Study Design: Retrospective Chart Review.Methods: Retrospective review of patients who underwent head and neck free flap reconstruction at our institution between 2009 to 2016.Results: Of the 145 patients that underwent head and neck tumor removal surgery using free tissue flaps to cover the defect and therafter received antibiotic prophylaxis, 30 (20.7%) developed postoperative surgical site (n = 17, 55.7%) or distant (n = 13, 43.4%) infections. Seven had a multidrug‐resistant infection, the most common with Methicillin‐Resistant Staphylococcus aureus (MRSA). There was no significant relationship between antibiotic spectrum or duration to the development of postoperative infections or MDRO. Pseudomonas and MRSA infections were low overall with only one multidrug‐resistant Pseudomonas infection.Conclusions: The choice of antibiotic prophylaxis should cover organisms these patients are at highest risk for including anaerobes and Gram‐negative organisms. A shorter duration of antibiotic prophylaxis should be considered given no increased risk of postoperative infection nor MDRO. Finally, one must be aware of the potential threat of multidrug‐resistant Pseudomonas and MRSA amongst this vulnerable population and identity these with culture driven treatment.Level of Evidence: 4 Laryngoscope, 131:E1881–E1887, 2021
- 1 November 2018
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 39 (6) , 785-787
Necrotizing epiglottitis treated with early surgical debridement: A case report
- 1 November 2018
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 39 (6) , 785-787
Necrotizing epiglottitis treated with early surgical debridement: A case report